These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 9627165)

  • 61. The physicochemistry of endotoxins in relation to bioactivity.
    Gutsmann T; Schromm AB; Brandenburg K
    Int J Med Microbiol; 2007 Sep; 297(5):341-52. PubMed ID: 17452014
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Anti-inflammatory therapies in sepsis and septic shock.
    Freeman BD; Natanson C
    Expert Opin Investig Drugs; 2000 Jul; 9(7):1651-63. PubMed ID: 11060768
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Compensatory anti-inflammatory response syndrome.
    Adib-Conquy M; Cavaillon JM
    Thromb Haemost; 2009 Jan; 101(1):36-47. PubMed ID: 19132187
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Cutting edge: bacterial lipoprotein induces endotoxin-independent tolerance to septic shock.
    Wang JH; Doyle M; Manning BJ; Blankson S; Wu QD; Power C; Cahill R; Redmond HP
    J Immunol; 2003 Jan; 170(1):14-8. PubMed ID: 12496376
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Induction of innate immune memory via microRNA targeting of chromatin remodelling factors.
    Seeley JJ; Baker RG; Mohamed G; Bruns T; Hayden MS; Deshmukh SD; Freedberg DE; Ghosh S
    Nature; 2018 Jul; 559(7712):114-119. PubMed ID: 29950719
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Endotoxin-core antibodies: time for a reappraisal?
    Barclay GR
    Intensive Care Med; 1999 May; 25(5):427-9. PubMed ID: 10401932
    [No Abstract]   [Full Text] [Related]  

  • 67. Regulation of receptor-dependent activation of the innate immune response.
    Ulevitch RJ
    J Infect Dis; 2003 Jun; 187 Suppl 2():S351-5. PubMed ID: 12792851
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Sepsis and septic shock.
    Zanetti G; Baumgartner JD; Glauser MP
    Schweiz Med Wochenschr; 1997 Mar; 127(12):489-99. PubMed ID: 9106949
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Molecular basis of host-pathogen interaction in septic shock.
    Heumann D; Glauser MP; Calandra T
    Curr Opin Microbiol; 1998 Feb; 1(1):49-55. PubMed ID: 10066457
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Circulating endotoxin and antiendotoxin antibodies during severe sepsis and septic shock.
    Maury E; Blanchard HS; Chauvin P; Guglielminotti J; Alzieu M; Guidet B; Offenstadt G
    J Crit Care; 2003 Jun; 18(2):115-20. PubMed ID: 12800122
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Molecular mechanisms of endotoxin activity.
    Schletter J; Heine H; Ulmer AJ; Rietschel ET
    Arch Microbiol; 1995 Dec; 164(6):383-9. PubMed ID: 8588739
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Antibodies to lipopolysaccharides: some diagnostic and protective aspects.
    Fomsgaard A
    APMIS Suppl; 1990; 18():1-38. PubMed ID: 2122911
    [No Abstract]   [Full Text] [Related]  

  • 73. Factors predisposing to bacterial invasion and infection.
    Heinzelmann M; Scott M; Lam T
    Am J Surg; 2002 Feb; 183(2):179-90. PubMed ID: 11918885
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Endotoxins and other sepsis triggers.
    Opal SM
    Contrib Nephrol; 2010; 167():14-24. PubMed ID: 20519895
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Pathophysiologic mechanisms in septic shock.
    King EG; Bauzá GJ; Mella JR; Remick DG
    Lab Invest; 2014 Jan; 94(1):4-12. PubMed ID: 24061288
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Globin attenuates the innate immune response to endotoxin.
    Yang H; Wang H; Bernik TR; Ivanova S; Wang H; Ulloa L; Roth J; Eaton JW; Tracey KJ
    Shock; 2002 Jun; 17(6):485-90. PubMed ID: 12069185
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [The role of cytokines in endotoxic shock and in endotoxin hypersensitivity].
    Freudenberg MA; Ness T; Kumazawa Y; Galanos C
    Immun Infekt; 1993 Apr; 21(2):40-4. PubMed ID: 8340136
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Novel therapies for sepsis: antiendotoxin therapies.
    Manocha S; Feinstein D; Kumar A; Kumar A
    Expert Opin Investig Drugs; 2002 Dec; 11(12):1795-812. PubMed ID: 12457439
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Western blot analysis of bile or intestinal fluid from patients with septic shock or systemic inflammatory response syndrome, using antibodies to TNF-alpha, IL-1 alpha and IL-1 beta.
    Belov L; Meher-Homji V; Putaswamy V; Miller R
    Immunol Cell Biol; 1999 Feb; 77(1):34-40. PubMed ID: 10101684
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Macrophage migration inhibitory factor and innate immune responses to bacterial infections.
    Froidevaux C; Roger T; Martin C; Glauser MP; Calandra T
    Crit Care Med; 2001 Jul; 29(7 Suppl):S13-5. PubMed ID: 11445727
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.